|
US8592384B2
(en)
|
2005-04-04 |
2013-11-26 |
The Board Of Regents Of The University Of Texas System |
Micro-RNA's that regulate muscle cells
|
|
DK2002003T3
(en)
*
|
2005-05-27 |
2016-03-21 |
Ospedale San Raffaele Srl |
Gene vector comprising miRNA
|
|
WO2006128245A1
(en)
*
|
2005-06-03 |
2006-12-07 |
Southern Adelaide Health Service-Flinders Medical Centre |
Targeting cells with altered microrna expression
|
|
DK2056882T3
(da)
|
2006-08-01 |
2012-11-19 |
Univ Texas |
Identifikation af en mikro-rna, som aktiverer ekspression af en tung kæde med beta-myosin
|
|
WO2008071959A1
(en)
*
|
2006-12-12 |
2008-06-19 |
Oxford Biomedica (Uk) Limited |
Lentiviral vectors comprising micrornas
|
|
EP2125032A4
(en)
|
2007-02-20 |
2011-02-23 |
Mayo Foundation |
CANCER TREATMENT WITH VIRAL NUCLEIC ACID
|
|
CA2694928A1
(en)
|
2007-07-31 |
2009-02-05 |
Board Of Regents, The University Of Texas System |
Micro-rnas that control myosin expression and myofiber identity
|
|
DK2182969T3
(en)
|
2007-07-31 |
2017-02-27 |
Univ Texas |
Micro-RNA family that modulates fibrosis and its applications
|
|
WO2009062169A2
(en)
|
2007-11-09 |
2009-05-14 |
The Board Of Regents Of The University Of Texas System |
Micro-rnas of the mir-15 family modulate cardiomyocyte survival and cardiac repair
|
|
WO2009117418A2
(en)
|
2008-03-17 |
2009-09-24 |
The Board Of Regents Of The University Of Texas System |
Identification of micro-rnas involved in neuromuscular synapse maintenance and regeneration
|
|
US20110098346A1
(en)
*
|
2008-05-19 |
2011-04-28 |
Agency For Science, Technology And Research |
Nucleic acid molecule and method of targeting gene expression to gliomas
|
|
US9217155B2
(en)
*
|
2008-05-28 |
2015-12-22 |
University Of Massachusetts |
Isolation of novel AAV'S and uses thereof
|
|
WO2010045659A1
(en)
|
2008-10-17 |
2010-04-22 |
American Gene Technologies International Inc. |
Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules
|
|
US9938540B2
(en)
|
2008-11-12 |
2018-04-10 |
Ospedale San Raffaele S.R.L. |
Gene vector for inducing transgene-specific immune tolerance
|
|
CN101787373B
(zh)
*
|
2009-01-23 |
2013-06-19 |
中国人民解放军第二军医大学东方肝胆外科医院 |
一种携带外源基因在包装细胞中高效生产的重组病毒载体、其构建方法及其用途
|
|
US8629119B2
(en)
|
2009-02-04 |
2014-01-14 |
The Board Of Regents, The University Of Texas System |
Dual targeting of MIR-208 and MIR-499 in the treatment of cardiac disorders
|
|
JP5871791B2
(ja)
*
|
2009-04-29 |
2016-03-01 |
アカデミス・メディス・セントルム・ベイ・デ・ウニフェルジテイト・ファン・アムステルダムＡｃａｄｅｍｉｓｃｈ Ｍｅｄｉｓｃｈ Ｃｅｎｔｒｕｍ Ｂｉｊ Ｄｅ Ｕｎｉｖｅｒｓｉｔｅｉｔ Ｖａｎ Ａｍｓｔｅｒｄａｍ |
心不全または心不全の危険性を中和、予防および／または決定する手段および方法
|
|
EP2425001A4
(en)
|
2009-04-30 |
2012-11-14 |
Univ California |
ANTI-HIV COMBINATION VECTORS, TARGETING VECTORS AND METHOD OF USE
|
|
MX2011011508A
(es)
*
|
2009-04-30 |
2012-02-13 |
San Raffaele Centro Fond |
Vector genico.
|
|
US8734809B2
(en)
|
2009-05-28 |
2014-05-27 |
University Of Massachusetts |
AAV's and uses thereof
|
|
EA022786B1
(ru)
|
2009-07-31 |
2016-03-31 |
Этрис Гмбх |
Рнк с комбинацией из немодифицированных и модифицированных нуклеотидов для экспрессии белков
|
|
DE102009050308A1
(de)
|
2009-10-22 |
2011-05-05 |
Ludwig-Maximilians-Universität München |
RNA mit einer Kombination aus unmodifizierten und modifizierten Nucleotiden zur Proteinexpression
|
|
WO2011020014A1
(en)
|
2009-08-14 |
2011-02-17 |
Regeneron Pharmaceuticals, Inc. |
Promoter-regulated differentiation-dependent self-deleting cassette
|
|
WO2011130749A2
(en)
|
2010-04-16 |
2011-10-20 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Identification of mutations in herpes simplex virus envelope glycoproteins that enable or enhance vector retargeting to novel non-hsv receptors
|
|
DK2561073T3
(en)
|
2010-04-23 |
2016-12-12 |
Univ Massachusetts |
Aav vectors targeted to central nervous system and methods of use thereof
|
|
CA2833912C
(en)
|
2010-04-23 |
2021-09-21 |
University Of Massachusetts |
Aav-based treatment of cholesterol-related disorders
|
|
CA3050894C
(en)
|
2010-04-23 |
2022-10-18 |
University Of Massachusetts |
Multicistronic expression constructs
|
|
US9309534B2
(en)
|
2010-07-12 |
2016-04-12 |
Universidad Autonoma De Barcelona |
Gene therapy composition for use in diabetes treatment
|
|
WO2012008302A1
(ja)
|
2010-07-12 |
2012-01-19 |
国立大学法人鳥取大学 |
ｍｉＲＮＡ導入による新規ｈｉＰＳＣ作製法
|
|
WO2012065027A2
(en)
|
2010-11-11 |
2012-05-18 |
University Of Miami |
Compositions, kits and methods for treatment of cardiovascular, immunological, and inflammatory diseases
|
|
EP2652151A2
(en)
|
2010-12-15 |
2013-10-23 |
Miragen Therapeutics |
Microrna inhibitors comprising locked nucleotides
|
|
WO2012143401A1
(en)
|
2011-04-18 |
2012-10-26 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Tissue-specific regulation of transgene expression
|
|
WO2012145624A2
(en)
|
2011-04-21 |
2012-10-26 |
University Of Massachusetts |
Raav-based compositions and methods for treating alpha-1 anti-trypsin deficiencies
|
|
ES2632212T3
(es)
*
|
2011-08-04 |
2017-09-11 |
Yeda Research And Development Co. Ltd. |
miR-135 y composiciones que lo comprenden para el tratamiento de afecciones médicas asociadas con la serotonina
|
|
ES2872081T3
(es)
|
2011-08-05 |
2021-11-02 |
Regeneron Pharma |
Ratones con cadena ligera universal humanizada
|
|
EP2758531B1
(en)
*
|
2011-09-23 |
2017-04-12 |
GE Healthcare Dharmacon, Inc. |
The introduction of modular vector elements during production of a lentivirus
|
|
EP2763703B1
(en)
|
2011-10-06 |
2018-02-14 |
Miragen Therapeutics, Inc. |
Control of whole body energy homeostasis by microrna regulation
|
|
EP2584040A1
(en)
|
2011-10-17 |
2013-04-24 |
Pharmahungary 2000 Kft. |
Compounds for treatment of ischemic injury
|
|
WO2013151664A1
(en)
|
2012-04-02 |
2013-10-10 |
modeRNA Therapeutics |
Modified polynucleotides for the production of proteins
|
|
US10501513B2
(en)
|
2012-04-02 |
2019-12-10 |
Modernatx, Inc. |
Modified polynucleotides for the production of oncology-related proteins and peptides
|
|
US10501512B2
(en)
|
2012-04-02 |
2019-12-10 |
Modernatx, Inc. |
Modified polynucleotides
|
|
WO2013152230A1
(en)
|
2012-04-04 |
2013-10-10 |
The Trustees Of Columbia University In The City Of New York |
Smooth muscle specific inhibition for anti-restenotic therapy
|
|
US9163235B2
(en)
|
2012-06-21 |
2015-10-20 |
MiRagen Therapeutics, Inc. |
Inhibitors of the miR-15 family of micro-RNAs
|
|
EP2864482A4
(en)
|
2012-06-21 |
2016-02-10 |
Miragen Therapeutics Inc |
OLIGONUCLEOTIDE INHIBITORS COMPRISING A BLOCKED NUCLEIC ACID PATTERN
|
|
CN103505743A
(zh)
*
|
2012-06-21 |
2014-01-15 |
北京命码生科科技有限公司 |
含功能性microRNA/siRNA的细胞微粒子及其应用
|
|
PT2922554T
(pt)
|
2012-11-26 |
2022-06-28 |
Modernatx Inc |
Arn modificado nas porções terminais
|
|
EP3434774A1
(en)
*
|
2013-01-17 |
2019-01-30 |
ModernaTX, Inc. |
Signal-sensor polynucleotides for the alteration of cellular phenotypes
|
|
RS61387B2
(sr)
|
2013-02-15 |
2024-06-28 |
Bioverativ Therapeutics Inc |
Gen optimizovanog faktora viii
|
|
DK3184641T3
(da)
|
2013-10-28 |
2020-08-03 |
Univ Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Onkolytisk hsv-vektor
|
|
US20150147774A1
(en)
*
|
2013-11-22 |
2015-05-28 |
National University Of Singapore |
Expression construct for yeast and a method of using the construct
|
|
WO2015127128A2
(en)
|
2014-02-19 |
2015-08-27 |
University Of Massachusetts |
Recombinant aavs having useful transcytosis properties
|
|
JP6756700B2
(ja)
|
2014-03-18 |
2020-09-16 |
ユニバーシティ オブ マサチューセッツ |
筋萎縮性側索硬化症を処置するためのｒＡＡＶベースの組成物および方法
|
|
WO2015164786A1
(en)
|
2014-04-25 |
2015-10-29 |
University Of Massachusetts |
Recombinant aav vectors useful for reducing immunity against transgene products
|
|
US11008561B2
(en)
|
2014-06-30 |
2021-05-18 |
Bioverativ Therapeutics Inc. |
Optimized factor IX gene
|
|
US10973931B2
(en)
|
2014-09-16 |
2021-04-13 |
Universitat Autònoma De Barcelona |
Adeno-associated viral vectors for the gene therapy of metabolic diseases
|
|
US10370432B2
(en)
|
2014-10-03 |
2019-08-06 |
University Of Massachusetts |
Heterologous targeting peptide grafted AAVS
|
|
WO2016065001A1
(en)
|
2014-10-21 |
2016-04-28 |
University Of Massachusetts |
Recombinant aav variants and uses thereof
|
|
US11085055B2
(en)
|
2014-12-05 |
2021-08-10 |
Universitat Autonoma De Barcelona |
Viral vectors for the treatment of diabetes
|
|
HK1249108A1
(zh)
|
2015-01-20 |
2018-10-26 |
米拉根医疗股份有限公司 |
Mir-92抑制剂及其用途
|
|
EP3256170B1
(en)
|
2015-02-13 |
2020-09-23 |
University of Massachusetts |
Compositions and methods for transient delivery of nucleases
|
|
US11046955B2
(en)
|
2015-04-24 |
2021-06-29 |
University Of Massachusetts |
Modified AAV constructs and uses thereof
|
|
US11980663B2
(en)
|
2015-07-08 |
2024-05-14 |
American Gene Technologies International Inc. |
HIV pre-immunization and immunotherapy
|
|
EP3359670B2
(en)
|
2015-10-05 |
2024-02-14 |
ModernaTX, Inc. |
Methods for therapeutic administration of messenger ribonucleic acid drugs
|
|
EP3364949A4
(en)
|
2015-10-22 |
2019-07-31 |
ModernaTX, Inc. |
CANCER VACCINES
|
|
US10188750B1
(en)
|
2015-10-23 |
2019-01-29 |
University Of South Florida |
Self-replicating cell selective gene delivery compositions, methods, and uses thereof
|
|
IL297238B2
(en)
|
2016-01-15 |
2024-08-01 |
American Gene Tech Int Inc |
Methods and preparations for gamma-delta T-cell activation
|
|
US10137144B2
(en)
|
2016-01-15 |
2018-11-27 |
American Gene Technologies International Inc. |
Methods and compositions for the activation of gamma-delta T-cells
|
|
AU2017212713B2
(en)
|
2016-01-27 |
2023-01-19 |
Oncorus, Inc. |
Oncolytic viral vectors and uses thereof
|
|
KR20180118659A
(ko)
|
2016-02-01 |
2018-10-31 |
바이오버라티브 테라퓨틱스 인크. |
최적화된 viii 인자 유전자
|
|
JP7153332B2
(ja)
|
2016-02-08 |
2022-10-14 |
アメリカン ジーン テクノロジーズ インターナショナル インコーポレイテッド |
Ｈｉｖワクチン接種および免疫療法
|
|
CA3012344A1
(en)
|
2016-02-12 |
2017-08-17 |
University Of Massachusetts |
Anti-angiogenic mirna therapeutics for inhibiting corneal neovascularization
|
|
ES2911448T3
(es)
|
2016-03-09 |
2022-05-19 |
American Gene Tech Int Inc |
Vectores combinados y métodos para el tratamiento del cáncer
|
|
ES2796488T3
(es)
*
|
2016-04-08 |
2020-11-27 |
Krystal Biotech Inc |
Composiciones para el uso en métodos para el tratamiento de heridas, trastornos y enfermedades de la piel
|
|
US12128113B2
(en)
*
|
2016-05-18 |
2024-10-29 |
Modernatx, Inc. |
Polynucleotides encoding JAGGED1 for the treatment of Alagille syndrome
|
|
WO2017213697A1
(en)
|
2016-06-08 |
2017-12-14 |
American Gene Technologies International Inc. |
Non-integrating viral delivery system and methods related thereto
|
|
EP3478321A4
(en)
|
2016-06-30 |
2020-04-22 |
Oncorus, Inc. |
PSEUDOTYPIZED ONCOLYTIC VIRAL ADMINISTRATION OF THERAPEUTIC POLYPEPTIDES
|
|
CA3028982A1
(en)
|
2016-07-08 |
2018-01-11 |
American Gene Technologies International Inc. |
Hiv pre-immunization and immunotherapy
|
|
GB201612214D0
(en)
|
2016-07-14 |
2016-08-31 |
Univ Oxford Innovation Ltd |
Method
|
|
WO2018017882A1
(en)
|
2016-07-21 |
2018-01-25 |
American Gene Technologies International Inc. |
Viral vectors for treating parkinson's disease
|
|
CN110073000A
(zh)
*
|
2016-07-26 |
2019-07-30 |
森迪生物科学公司 |
遗传擦除子
|
|
JP2018029521A
(ja)
*
|
2016-08-24 |
2018-03-01 |
国立研究開発法人農業・食品産業技術総合研究機構 |
ｍｉＲ３９８標的核酸配列を含む、遺伝子導入のためのウイルスベクター
|
|
US10457940B2
(en)
|
2016-09-22 |
2019-10-29 |
University Of Massachusetts |
AAV treatment of Huntington's disease
|
|
KR20190075964A
(ko)
|
2016-10-13 |
2019-07-01 |
유니버시티 오브 매사추세츠 |
Aav 캡시드 설계
|
|
WO2018127702A1
(en)
|
2017-01-06 |
2018-07-12 |
Stabilitech Biopharma Ltd |
Virus
|
|
CN107384868A
(zh)
*
|
2017-02-17 |
2017-11-24 |
中国农业科学院上海兽医研究所 |
永生化原代绵羊肺细胞系的构建及其应用
|
|
CN117821509A
(zh)
|
2017-04-03 |
2024-04-05 |
编码治疗公司 |
组织选择性转基因表达
|
|
US11820999B2
(en)
|
2017-04-03 |
2023-11-21 |
American Gene Technologies International Inc. |
Compositions and methods for treating phenylketonuria
|
|
KR102945203B1
(ko)
*
|
2017-05-08 |
2026-03-31 |
시애틀 프로젝트 코포레이션 |
알파바이러스 신생항원 벡터
|
|
US11576872B2
(en)
|
2017-05-08 |
2023-02-14 |
Flagship Pioneering Innovations V, Inc. |
Compositions for facilitating membrane fusion and uses thereof
|
|
AU2018264996A1
(en)
|
2017-05-09 |
2019-12-05 |
University Of Massachusetts |
Methods of treating Amyotrophic Lateral Sclerosis (ALS)
|
|
CA3099990A1
(en)
|
2017-05-12 |
2018-11-15 |
University Of Massachusetts |
Viral vector production
|
|
KR102765034B1
(ko)
|
2017-05-24 |
2025-02-11 |
유니버시타트 아우토노마 데 바르셀로나 |
섬유아세포 성장 인자 21 (ｆｇｆ21) 코딩 서열을 포함하는 바이러스 발현 컨스트럭트
|
|
US12559769B2
(en)
|
2017-06-16 |
2026-02-24 |
American Gene Technologies International Inc. |
Methods and compositions for the activation of tumor cytotoxicity via human gamma-delta t-cells
|
|
US20190016802A1
(en)
|
2017-07-14 |
2019-01-17 |
Immatics Biotechnologies Gmbh |
Dual specificity polypeptide molecule
|
|
MX2020000993A
(es)
*
|
2017-07-26 |
2020-07-22 |
Oncorus Inc |
Vectores virales oncolíticos y usos de estos.
|
|
IT201700086403A1
(it)
*
|
2017-07-27 |
2019-01-27 |
Univ Del Piemonte Orientale |
Endothelial-specific promoter sequences and uses thereof
|
|
MX2020001593A
(es)
|
2017-08-09 |
2020-07-13 |
Bioverativ Therapeutics Inc |
Moleculas de acido nucleico y usos de las mismas.
|
|
EP3444347A1
(en)
|
2017-08-18 |
2019-02-20 |
Universität Heidelberg |
Use of anti-crispr polypeptides for specific activation of cas nucleases
|
|
CN118006607A
(zh)
|
2017-09-22 |
2024-05-10 |
马萨诸塞大学 |
Sod1双表达载体及其用途
|
|
CA3077594C
(en)
*
|
2017-10-10 |
2022-11-29 |
Nantbio, Inc. |
Modified ec7 cells having low toxicity to viral production payloads
|
|
CN118345115A
(zh)
|
2017-12-01 |
2024-07-16 |
编码治疗公司 |
工程化的dna结合蛋白
|
|
IL275273B2
(en)
*
|
2017-12-15 |
2024-09-01 |
Medizinische Hochschule Hannover |
Improved compound for treatment of heart failure
|
|
WO2019133847A1
(en)
|
2017-12-29 |
2019-07-04 |
Oncorus, Inc. |
Oncolytic viral delivery of therapeutic polypeptides
|
|
KR20240134250A
(ko)
|
2018-01-04 |
2024-09-06 |
아이코닉 테라퓨틱스, 인코포레이티드 |
항-조직 인자 항체, 항체-약물 결합체, 및 관련 방법
|
|
US20210038744A1
(en)
|
2018-02-01 |
2021-02-11 |
Bioverativ Therapeutics Inc. |
Use of lentiviral vectors expressing factor viii
|
|
US10716866B2
(en)
|
2018-03-29 |
2020-07-21 |
Generoath Co., Ltd |
Pharmaceutical composition comprising AIMP2-DX2 for preventing or treating neuronal diseases and use thereof
|
|
CN112367973A
(zh)
|
2018-05-15 |
2021-02-12 |
旗舰先锋创新V股份有限公司 |
融合剂脂质体组合物和其用途
|
|
CA3105953A1
(en)
|
2018-07-09 |
2020-01-16 |
Flagship Pioneering Innovations V, Inc. |
Fusosome compositions and uses thereof
|
|
JP7602454B2
(ja)
|
2018-08-09 |
2024-12-18 |
バイオベラティブ セラピューティクス インコーポレイテッド |
核酸分子及び非ウイルス遺伝子治療のためのそれらの使用
|
|
KR20210102870A
(ko)
|
2018-08-30 |
2021-08-20 |
테나야 테라퓨틱스, 인코포레이티드 |
미오카르딘 및 ascl1을 사용한 심장 세포 재프로그래밍
|
|
US12281321B2
(en)
|
2018-09-28 |
2025-04-22 |
Voyager Therapeutics, Inc. |
Frataxin expression constructs having engineered promoters and methods of use thereof
|
|
JP2022513347A
(ja)
*
|
2018-10-11 |
2022-02-07 |
アイドゲノーシッシェ テヒニッシェ ホッホシューレ チューリッヒ |
高度にコンパクトな多入力論理ゲートをコードする核酸ベクターを使用して疾患を処置する方法
|
|
EP3876952A4
(en)
|
2018-11-05 |
2022-08-24 |
American Gene Technologies International Inc. |
VECTOR SYSTEM FOR EXPRESSING REGULATORY RNA
|
|
KR20210090650A
(ko)
|
2018-11-07 |
2021-07-20 |
그릿스톤 바이오, 인코포레이티드 |
알파바이러스 신생항원 벡터 및 인터페론 억제제
|
|
KR20210131991A
(ko)
|
2018-11-14 |
2021-11-03 |
플래그쉽 파이어니어링 이노베이션스 브이, 인크. |
구획-특이적 카고 전달을 위한 조성물 및 방법
|
|
US20230048166A1
(en)
|
2018-11-14 |
2023-02-16 |
Flagship Pioneering Innovations V, Inc. |
Fusosome compositions for hematopoietic stem cell delivery
|
|
WO2020102503A2
(en)
|
2018-11-14 |
2020-05-22 |
Flagship Pioneering Innovations V, Inc. |
Fusosome compositions for t cell delivery
|
|
EP3880179A2
(en)
*
|
2018-11-14 |
2021-09-22 |
Flagship Pioneering Innovations V, Inc. |
Fusosome compositions for cns delivery
|
|
US11421273B2
(en)
*
|
2018-12-03 |
2022-08-23 |
California Institute Of Technology |
In situ readout of DNA barcodes
|
|
CA3121786A1
(en)
|
2018-12-06 |
2020-06-11 |
Bioverativ Therapeutics Inc. |
Use of lentiviral vectors expressing factor ix
|
|
MX2021007600A
(es)
*
|
2018-12-21 |
2021-08-11 |
Univ Pennsylvania |
Composiciones para la reduccion de la expresion transgenica especifica de drg.
|
|
CA3124524A1
(en)
*
|
2019-01-04 |
2020-07-09 |
Oncorus, Inc. |
Encapsulated rna polynucleotides and methods of use
|
|
KR102248420B1
(ko)
*
|
2019-03-15 |
2021-05-06 |
주식회사 제너로스 |
miR-142-3p의 표적 서열을 포함하는 재조합 벡터
|
|
WO2020219766A1
(en)
*
|
2019-04-24 |
2020-10-29 |
The Trustees Of The University Of Pennsylvania |
Compositions useful in treatment of rett syndrome
|
|
SG11202113048SA
(en)
|
2019-05-29 |
2021-12-30 |
Encoded Therapeutics Inc |
Compositions and methods for selective gene regulation
|
|
SG11202113187WA
(en)
|
2019-05-30 |
2021-12-30 |
Gritstone Bio Inc |
Modified adenoviruses
|
|
EP4031673A1
(en)
|
2019-09-19 |
2022-07-27 |
Genethon |
Gene therapy expression system alleviating cardiac toxicity of fkrp
|
|
JP7803014B2
(ja)
|
2019-09-30 |
2026-01-21 |
バイオベラティブ セラピューティクス インコーポレイテッド |
レンチウイルスベクター製剤
|
|
KR102461417B1
(ko)
*
|
2019-11-11 |
2022-11-01 |
주식회사 온코크로스 |
아데노바이러스 벡터를 포함하는 전립선암 진단용 조성물
|
|
US20230210883A1
(en)
*
|
2020-03-13 |
2023-07-06 |
Duke University |
Compositions for the treatment of nash and associated disorders and methods of using same
|
|
MX2022012059A
(es)
*
|
2020-03-30 |
2023-02-14 |
Greffex Inc |
Aumento de la produccion de vectores de genetransferencia a base de adenovirus.
|
|
JP7862321B2
(ja)
*
|
2020-04-27 |
2026-05-19 |
ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア |
Ｃｄｋｌ５欠損症（ｃｄｄ）の治療において有用な組成物
|
|
IL298138A
(en)
*
|
2020-05-12 |
2023-01-01 |
Univ Pennsylvania |
Compositions for drg-specific reduction of transgene expression
|
|
CN115996758A
(zh)
|
2020-06-19 |
2023-04-21 |
吉尼松公司 |
使sgcg在肌肉和心脏中充分表达的基因治疗表达系统
|
|
JP2023537565A
(ja)
|
2020-06-24 |
2023-09-04 |
バイオベラティブ セラピューティクス インコーポレイテッド |
タンパク質を発現するように改変されたレンチウイルスベクターの調製物から遊離第ｖｉｉｉ因子を除去する方法
|
|
BR112023000305A2
(pt)
|
2020-07-10 |
2023-03-21 |
Genethon |
Promotor, sistema de expressão e composição farmacêutica
|
|
IL300026A
(en)
|
2020-08-06 |
2023-03-01 |
Gritstone Bio Inc |
Multiepitope vaccine cassettes
|
|
AU2021330936A1
(en)
|
2020-08-23 |
2023-05-04 |
Bioverativ Therapeutics Inc. |
MODIFIED BACULOVIRUS SYSTEM FOR IMPROVED PRODUCTION OF CLOSED-ENDED DNA (ceDNA)
|
|
KR102626543B1
(ko)
*
|
2020-09-14 |
2024-01-23 |
주식회사 제너로스 |
AIMP2-DX2 및 miR-142의 표적 핵산을 포함하는 재조합 벡터
|
|
KR20220035693A
(ko)
*
|
2020-09-14 |
2022-03-22 |
주식회사 제너로스 |
표적화된 유전자 전달을 위한 아데노-부속 바이러스 벡터
|
|
JP7121086B2
(ja)
*
|
2020-09-25 |
2022-08-17 |
ウニベルシダッド アウトノマ デ バルセロナ |
脂肪組織に形質導入するのに有用なアデノ随伴ウイルスベクター
|
|
EP4221760A4
(en)
*
|
2020-09-30 |
2025-08-13 |
Generoath Co Ltd |
METHODS OF TREATING AGE-RELATED MACULAR DISEASES USING AIMP2-DX2 AND OPTIONALLY A TARGET SEQUENCE FOR MIR-142 AND RELATED COMPOSITIONS
|
|
WO2022233956A1
(en)
|
2021-05-05 |
2022-11-10 |
Immatics Biotechnologies Gmbh |
Antigen binding proteins specifically binding prame
|
|
MX2023013394A
(es)
*
|
2021-05-13 |
2023-12-14 |
Akouos Inc |
Composiciones de suministro de terapia genica y metodos para tratar perdida auditiva.
|
|
US20230084036A1
(en)
|
2021-08-23 |
2023-03-16 |
Bioverativ Therapeutics Inc. |
Optimized factor viii genes
|
|
WO2023028440A2
(en)
|
2021-08-23 |
2023-03-02 |
Bioverativ Therapeutics Inc. |
Baculovirus expression system
|
|
KR20240067122A
(ko)
|
2021-09-30 |
2024-05-16 |
바이오버라티브 테라퓨틱스 인크. |
감소된 면역원성을 갖는 인자 viii 폴리펩타이드를 암호화하는 핵산
|
|
WO2023142040A1
(en)
*
|
2022-01-29 |
2023-08-03 |
Virogin Biotech Canada Ltd. |
Transcriptional and translational dual regulated oncolytic herpes simplex virus vectors
|
|
CN119343154A
(zh)
*
|
2022-05-13 |
2025-01-21 |
杰内罗蒂股份有限公司 |
使用AIMP2-DX2和任选的miR-142靶序列及其组合物治疗视网膜退行性疾病的方法
|
|
KR20260042228A
(ko)
|
2023-07-24 |
2026-03-30 |
스트랜드 세러퓨틱스 인코포레이티드 |
체외 세포 요법을 위한 조작된 면역 세포를 생산하기 위한 rna 기반 합성 회로
|
|
US12281311B1
(en)
*
|
2024-02-20 |
2025-04-22 |
Wyvern Pharmaceuticals Inc. |
Composition for regulating production of interfering ribonucleic acid
|